Diazoxide for Neonatal Hyperinsulinemic Hypoglycemia and Pulmonary Hypertension
Hypoglycemia in neonates is associated with long-term neurodevelopmental effects. Hyperinsulinemic hypoglycemia (HH) is the most common cause of persistent hypoglycemia in neonatal intensive care units. Diazoxide is the only medication that is currently recommended for treatment of HH in neonates. H...
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artikkeli |
| Kieli: | English |
| Julkaistu: |
MDPI AG
2022-12-01
|
| Sarja: | Children |
| Aiheet: | |
| Linkit: | https://www.mdpi.com/2227-9067/10/1/5 |